pillbase.ru

NELARABINE

Active substance: nelarabine

INJECTION · NELARABINE 5 mg/mL

United StatesActive

Marketing holder: Alembic Pharmaceuticals Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 3
  • Атрианс®
    раствор для инфузий, 5 мг/мл, 50 мл (original in Russian, GRLS)
    ЛП-№(009155)-(РГ-RU)
    Сандоз д.д.
  • Атрианс®
    раствор для инфузий, 5 мг/мл, 50 мл (original in Russian, GRLS)
    ЛСР-009514/08
    Сандоз д.д.
  • Неларабин
    субстанция-порошок, ~, 0.5 кг (original in Russian, GRLS)
    ФС-002266
    Общество с ограниченной ответственностью "БИОН" (ООО "БИОН")
EU 1
  • Atriance
    nelarabine
    EMEA/H/C/000752
    Sandoz Pharmaceuticals d.d.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-a182-7478-a206-bd302dbd0be5,01a120c6-6e2d-7aea-acb1-80ec20078803;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-5df0-7afd-88af-4bc7118775dc,01a1208c-c1bf-7091-840a-43fb2478fef2,01a1208d-6081-7358-8ad7-c73ab9b7f04d,01a1208e-d6d4-718c-9e50-7cf7cf768126,01a12092-876b-7b35-bb9a-14a92cb9a4c7;count=15 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
62332-813
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 62332-813 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 62332-813 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 62332-813 · Verified 2026-10-09 · open in source